chitosan has been researched along with Keratoconus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz-Tomé, V; García-Otero, X; González-Barcia, M; Lema, MI; López-López, M; Otero-Espinar, FJ; Regueiro, U; Varela-Fernández, R | 1 |
| Conde Penedo, A; Díaz Tomé, V; Fernández Ferreiro, A; González Barcia, M; Otero Espinar, FJ | 1 |
2 other study(ies) available for chitosan and Keratoconus
| Article | Year |
|---|---|
Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan/TPP and Chitosan/Sulfobutylether-β-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment.
Topics: Animals; Anti-Infective Agents; beta-Cyclodextrins; Cattle; Chickens; Chitosan; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Humans; Keratoconus; Lactoferrin; Male; Nanoparticles; Rats, Sprague-Dawley | 2021 |
Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
Topics: Administration, Ophthalmic; Animals; Arginine; Cattle; Chickens; Chitosan; Chorioallantoic Membrane; Cornea; Cyclodextrins; Drug Compounding; Emulsions; Excipients; Humans; Keratoconus; Nanoparticles; Ophthalmic Solutions; Permeability; Riboflavin; Solubility; Solutions; Toxicity Tests, Acute | 2021 |